Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | RAC-alpha serine/threonine-protein kinase | ||
Ligand | BDBM50170284 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_2265681 | ||
IC50 | 0.066000±n/a nM | ||
Citation | Huang, J; Chen, L; Wu, J; Ai, D; Zhang, JQ; Chen, TG; Wang, L Targeting the PI3K/AKT/mTOR Signaling Pathway in the Treatment of Human Diseases: Current Status, Trends, and Solutions. J Med Chem65:16033-16061 (2022) [PubMed] | ||
More Info.: | Get all data from this article, Assay Method | ||
RAC-alpha serine/threonine-protein kinase | |||
Name: | RAC-alpha serine/threonine-protein kinase | ||
Synonyms: | AKT phosphorylation (p-AKT) | AKT1 | AKT1/PPP1CA | AKT1_HUMAN | C-AKT | PKB | PKB alpha | Protein kinase Akt-1 | Protein kinase B | Protein kinase B (AKT1) | Protein kinase B (Akt 1) | Protein kinase B (Akt) | Protein kinase B alpha | Protein kinase B alpha (AKT1) | Proto-oncogene Akt (Akt1) | Proto-oncogene c-Akt (AKT) | Proto-oncogene c-Akt (AKT1) | RAC | RAC-PK-alpha | RAC-alpha serine/threonine-protein kinase (AKT) | RAC-alpha serine/threonine-protein kinase (AKT1) | RAC-alpha serine/threonine-protein kinase (pAKT) | ||
Type: | Enzyme | ||
Mol. Mass.: | 55681.25 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P31749 | ||
Residue: | 480 | ||
Sequence: |
| ||
BDBM50170284 | |||
n/a | |||
Name | BDBM50170284 | ||
Synonyms: | GSK2141795 | GSK2141795C | Uprosertib | ||
Type | Small organic molecule | ||
Emp. Form. | C18H16Cl2F2N4O2 | ||
Mol. Mass. | 429.248 | ||
SMILES | Cn1ncc(Cl)c1-c1cc(oc1Cl)C(=O)N[C@H](CN)Cc1ccc(F)c(F)c1 |r,wD:16.18,(2.37,-.54,;3.52,.49,;3.36,2.02,;4.77,2.65,;5.8,1.51,;7.33,1.67,;5.03,.17,;5.65,-1.23,;7.16,-1.55,;7.32,-3.09,;5.91,-3.71,;4.88,-2.57,;3.35,-2.73,;8.65,-3.86,;9.99,-3.09,;8.65,-5.4,;9.99,-6.17,;11.32,-5.4,;12.65,-6.17,;9.99,-7.71,;11.32,-8.48,;12.65,-7.71,;13.99,-8.48,;13.99,-10.02,;15.32,-10.79,;12.65,-10.79,;12.65,-12.33,;11.32,-10.02,)| | ||
Structure |